Scientists discover new drug to treat COVID-19
In a new study, researchers have identified a drug with the potential to provide treatment for COVID-19.
The research was conducted by a team from...
Men with physical jobs have over 50% higher dementia risk, shows study
Men in jobs with hard physical work have a higher risk of developing dementia compared to men doing sedentary work, new research reveals.
Based on...
Why people with dementia go missing
People with dementia are more likely to go missing in areas where road networks are dense, complicated and disordered, according to new research from...
Remdesivir for COVID-19: FDA approved but still unproven
The United States has become the epicenter of the world in the ever-increasing pandemic of COVID-19.
While public health prevention strategies of social distancing, crowd...
Common diabetes drugs could help prevent Parkinson’s disease
Elevated risk of Parkinson's disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds...
Scientists find new way to treat common retinal diseases
Scientists at Scripps Research have uncovered a potential new strategy for treating eye diseases that affect millions of people around the world, often resulting...
High blood pressure patients are not more likely to have severe COVID-19, says study
Fears that people with high blood pressure are more at risk from severe COVID-19 because it is easier for the virus to enter their...
Why motivation to learn declines with age
As people age, they often lose their motivation to learn new things or engage in everyday activities.
In a study of mice, MIT neuroscientists have...
This patch could help heal broken hearts
According to the American Heart Association, heart disease is the leading cause of death worldwide in recent years.
During a heart attack, or myocardial infarction...
COVID-19 patients’ antibodies could last for at least five months
Researchers who studied antibody responses in 30,000 patients with mild-to-moderate COVID-19 report that the patients' antibodies were relatively stable for at least five months.
Although...